Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment-论文-万方医学网

首页> > Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment

Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment

导出原文传递

翻译打印收藏纠错

第一作者： Juris J. Meier

作者： Juris J. Meier ^[1] ; Daniel R. Quast ^[2] ; Michael A. Nauck ^[3] ; Nina Schenker ; Carolyn F. Deacon ; Jens J. Holst ; Leona Plum‐M?rschel ; Christoph Kapitza

作者单位： Diabetes Division, St Josef‐Hospital,Ruhr‐University Bochum ^[1] Department of Biomedical Sciences and NovoNordisk Centre for Basic Metabolic Research, Faculty of ^[2] Profil ^[3]

关键词 DPP‐4 inhibitor GIP GLP‐1 linagliptin renal impairment type 2 diabetes mellitus

发布时间 2022-06-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment

相似文献

同项目论文

相关期刊

检索历史 清除

Acute effects of linagliptin on intact and total glucagon‐like peptide‐1 and gastric inhibitory polypeptide levels in insulin‐dependent type 2 diabetes patients with and without moderate renal impairment

相似文献

同项目论文

相关期刊

检索历史清除